"Conheça os nossos valores essenciais: Comprometimento; Humanização; Transparência; Responsabilidade Social; Credibilidade; Corresponsabilidade; Ética."

During the past decade, Santa Casa de Misericórdia de Votuporanga conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Santa Casa de Misericórdia de Votuporanga" #1 sponsor was "Hospital Israelita Albert Einstein" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Hospital Alemão Oswaldo Cruz" with 2 trials sponsored and "Population Health Research Institute" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Casa de Misericórdia de Votuporanga" #1 collaborator was "Brazilian Research In Intensive Care Network" with 5 trials as a collaborator, "Hospital do Coracao" with 5 trials as a collaborator, "Hospital Israelita Albert Einstein" with 4 trials as a collaborator, "Hospital Sirio-Libanes" with 4 trials as a collaborator and "Bayer" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Santa Casa de Misericórdia de Votuporanga" are "COVID-19" (4 trials), "COVID-19 Pneumonia" (2 trials), "Coronavirus Infection" (2 trials), "Heart Failure" (2 trials) and "Pneumonia, Viral" (2 trials). Many other conditions were trialed in "Santa Casa de Misericórdia de Votuporanga" in a lesser frequency.

Most popular intervention types in "Santa Casa de Misericórdia de Votuporanga" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Empagliflozin" (3 trials), "Hydroxychloroquine" (2 trials), "Leronlimab" (2 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Casa de Misericórdia de Votuporanga" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Santa Casa de Misericórdia de Votuporanga". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Santa Casa de Misericórdia de Votuporanga, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Santa Casa de Misericórdia de Votuporanga, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".